Amgen discusses biotech and pharma trends with Wells Fargo, where Thomas Dittrich serves as the company's Chief Financial Officer.
1 report, 1 independent
Updated Sep 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen discusses biotech and pharma trends with Wells Fargo, where Thomas Dittrich serves as the company's Chief Financial Officer.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Wells Fargo
American multinational banking and financial services company
-
Thomas Dittrich
Columbian physicist
Nothing else this week.
Related events
- Biogen executives spoke at a conference hosted by Wells Fargo on September 12, 2026.
- Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
- GSK and Amgen are major biopharma players.
- Richard K. Davis was appointed to the boards of directors of several companies, including Mastercard, Wells Fargo, and others, which are recognized technology companies.
- Veeva Systems and Wells Fargo discussed strategy at a major financial institution event.